1. Home
  2. CCD vs EMBC Comparison

CCD vs EMBC Comparison

Compare CCD & EMBC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Calamos Dynamic Convertible & Income Fund

CCD

Calamos Dynamic Convertible & Income Fund

HOLD

Current Price

$23.19

Market Cap

629.2M

Sector

Finance

ML Signal

HOLD

Logo Embecta Corp.

EMBC

Embecta Corp.

HOLD

Current Price

$8.85

Market Cap

525.3M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
CCD
EMBC
Founded
2014
1924
Country
United States
United States
Employees
N/A
1850
Industry
Trusts Except Educational Religious and Charitable
Medical/Dental Instruments
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
629.2M
525.3M
IPO Year
N/A
2021

Fundamental Metrics

Financial Performance
Metric
CCD
EMBC
Price
$23.19
$8.85
Analyst Decision
Buy
Analyst Count
0
2
Target Price
N/A
$18.50
AVG Volume (30 Days)
105.6K
803.2K
Earning Date
01-01-0001
05-08-2026
Dividend Yield
10.61%
6.76%
EPS Growth
N/A
20.90
EPS
N/A
0.74
Revenue
N/A
N/A
Revenue This Year
N/A
$1.17
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
$12.00
Revenue Growth
N/A
N/A
52 Week Low
$19.17
$8.47
52 Week High
$23.40
$15.55

Technical Indicators

Market Signals
Indicator
CCD
EMBC
Relative Strength Index (RSI) 63.53 39.62
Support Level $20.30 $8.60
Resistance Level N/A $9.36
Average True Range (ATR) 0.63 0.35
MACD 0.25 0.06
Stochastic Oscillator 94.57 40.38

Price Performance

Historical Comparison
CCD
EMBC

About CCD Calamos Dynamic Convertible & Income Fund

Calamos Dynamic Convertible and Income Fund operates as a diversified, closed-end management investment company. The fund's investment objective is to provide total return through a combination of current income and capital appreciation. It predominantly invests in a portfolio of convertible securities, investment grade and below investment grade bonds, loans, equity-linked notes, and floating rate securities.

About EMBC Embecta Corp.

Embecta Corp is a medical device company focused on providing solutions to improve the health and well-being of people living with diabetes. It has a broad portfolio of marketed products, including various pen needles, syringes, and safety devices, which are complemented by a proprietary digital application designed to assist people with managing their diabetes. The company predominantly sells products to wholesalers and distributors that sell to retail and institutional channels who in turn sell to patients or use the products to deliver insulin injections to patients. It also provides contract manufacturing services. Geographically, the company derives a majority of its revenue from the United States.

Share on Social Networks: